TheraSphere HUD For Treatment of Unresectable Hepatocellular Carcinoma (HCC) (TheraSphere)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00683631
Recruitment Status : Completed
First Posted : May 23, 2008
Last Update Posted : October 21, 2013
MDS Pharma Services
Information provided by (Responsible Party):
Robert C. Martin, University of Louisville

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : July 2012
  Study Completion Date : July 2012